Management of recurrent viral Hepatitis B and C after liver transplantation

被引：3
|
作者：
Montalbano M. [1 ]
Neff G.W. [1 ]
机构：
[1] University of Cincinnati, Cincinnati, OH 45267-0595
来源：
Current Gastroenterology Reports | 2006年 / 8卷 / 1期
关键词：
Lamivudine; Adefovir; Tenofovir Disoproxil Fumarate; Liver Transplant Recipient; Sustained Viral Response;
D O I：
10.1007/s11894-006-0065-x
中图分类号：
学科分类号：
摘要：
Liver transplant teams are often faced with the challenges of managing viral recurrence after liver transplantation. Hepatitis C virus (HCV) remains the most challenging viral disease in the transplant community. Strategies to prevent and delay viral recurrence have slowly developed over the past 5 years. Hepatitis B virus (HBV), previously a contra-indication for liver transplantation due to recurrence and cholestasis with allograft failure, is now one of the more favorable indications for liver transplantation as a result of current therapeutic options. This review investigates the up-to-date information on treatment-outcomes for HCV and HBV in the period following liver transplant. Copyright © 2006 by Current Science Inc.
引用
收藏
页码：60 / 66
页数：6
相关论文
共 50 条
  • [31] Viral hepatitis after liver transplantation
    Berenguer, Marina
    HEPATOLOGY RESEARCH, 2007, 37 : S279 - S286
  • [32] Histological course of recurrent hepatitis C after liver transplantation
    Neumann, UP
    Berg, T
    Bahra, M
    Langrehr, JM
    Neuhaus, P
    JOURNAL OF HEPATOLOGY, 2003, 38 : 46 - 46
  • [33] Trends in treatment of recurrent hepatitis C after liver transplantation
    Forgan-Smith, K. R.
    Stuart, K. A.
    Tallis, C.
    Macdonald, G. A.
    Fawcett, J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 174 - 175
  • [34] Ledipasvir and sofosbuvir for recurrent hepatitis C after liver transplantation
    Oya, Yuki
    Sugawara, Yasuhiko
    Watanabe, Takehisa
    Yoshimaru, Yoko
    Honda, Masaki
    Hashimoto, Shintaro
    Yoshii, Daiki
    Isono, Kaori
    Hayashida, Shintaro
    Yamamoto, Hidekazu
    Tanaka, Motohiko
    Sasaki, Yutaka
    Inomata, Yukihiro
    BIOSCIENCE TRENDS, 2016, 10 (06) : 496 - 499
  • [35] Natural history of recurrent hepatitis C after liver transplantation
    Malkan, G
    Humar, A
    Lilly, L
    Greig, PD
    Grant, D
    Wanless, IW
    Cameron, R
    Levy, GA
    Cattrall, MS
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1468 - 1468
  • [36] RECURRENT HEPATITIS-C AFTER LIVER-TRANSPLANTATION
    BELLI, LS
    ALBERTI, A
    RONDINARA, GF
    DECARLIS, L
    ROMANI, F
    BELLATI, G
    MINOLA, E
    ZURLENI, F
    ROSSETTI, O
    PIROTTA, V
    RIMOLDI, P
    ASTI, L
    IDEO, G
    BELLI, L
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (04) : 2635 - 2637
  • [37] Prevention and treatment of recurrent hepatitis C after liver transplantation
    Price J.C.
    Current Hepatitis Reports, 2013, 12 (4) : 227 - 235
  • [38] Management of hepatitis C infection after liver transplantation
    Alsatie, Mazen
    Chalasani, Naga
    Kwo, Paul Y.
    DRUGS, 2007, 67 (06) : 871 - 885
  • [39] Management of Hepatitis C Infection after Liver Transplantation
    Mazen Alsatie
    Naga Chalasani
    Paul Y. Kwo
    Drugs, 2007, 67 : 871 - 885
  • [40] Recurrence and management of hepatitis C after liver transplantation
    Oh, KB
    Lee, SG
    Lee, YJ
    Park, KM
    Hwang, S
    Kim, KH
    Ahn, CS
    Moon, DB
    Chu, CW
    Ha, TY
    Cho, SH
    Yang, HS
    Min, PC
    LIVER TRANSPLANTATION, 2003, 9 (06) : C45 - C45
12345